H2A Admin Core
H2A 管理核心
基本信息
- 批准号:10471412
- 负责人:
- 金额:$ 22.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-09 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdvocateAfricaAfrica South of the SaharaAfricanAgeBiological Specimen BanksCell NucleusClinicalCollaborationsCommunicationCommunitiesComputer softwareCountryData CollectionDatabase Management SystemsDevelopmentDocumentationElectronic MailEnsureFaceGenerationsGoalsGrantHIVHepatitis BHepatitis B VirusHepatitis C virusHumanInfectionInterceptInternationalInterruptionLeadLeadershipLinkMalignant NeoplasmsMedicalMentorsMonitorOnline SystemsPatient RecruitmentsPatientsPeer ReviewPeriodicityPoliciesPreparationPrimary carcinoma of the liver cellsProblem SolvingProgress ReportsPublic RelationsPublicationsReportingResearchResearch PersonnelResourcesReview LiteratureRisk FactorsRoleSchistosoma mansonii infectionSenegalSiteStructureSupervisionTimeTrainingUgandaUniversitiesWorkchronic infectiondata harmonizationdata sharingexpectationhuman subject protectionmeetingsorganizational structureparticipant retentionprogramssymposiumweb site
项目摘要
Hepatocellular carcinoma (HCC) is a very common and lethal cancer in Africa, and as patients with HIV live
longer, the HCC burden may increase. In prior studies, our team identified chronic infection with hepatitis B
and C viruses (HBV, HCV), HIV and Schistosomiasis mansoni as independent risk factors for HCC. Compared
to the US, HCC in sub-Saharan Africa occurs at younger age and more advanced stage with survival of only
months. Proposed is an East and West African partnership between colleagues at Makerere University in
Uganda, Fann University in Senegal and Johns Hopkins University focused on HIV and hepatocellular
carcinoma (HCC) in Africa: The H2A Consortium. Building on long-standing collaborative research, mentoring
and clinical activities in both countries, our overarching goal is to reduce the heavy burden of HCC in sub-
Saharan Africa. We advocate investigating cancer interception strategies using appropriate medical treatments
to interrupt or reverse the impact of these HCC-causing infections. The Administrative and Coordinating
Core (ACC) will provide overall leadership for implementing the scientific agenda of the H2A consortium. Using
best practices from decades of international research collaboration, the H2A Consortium proposes an effective
organizational structure and strong leadership with a track record of international research collaboration. The
organizational framework builds upon the ongoing close working relationship between prior co-PIs from
Uganda and Hopkins and welcomes the Senegalese team as equal partners. The ACC will establish
transparent structures to support rigorous study oversight, effective communication, and efficient problem-
solving. The H2A Consortium effectively integrates ACC activities within a closely interacting Steering
Committee (SC) comprised of the Overall Co-Leaders and the Project /Core PIs. For each Project or Core, the
leadership represents an equitable partnership with PIs from each site sharing responsibilities. This leadership
nucleus is further supported by an External Advisory Panel (EAP) and a Community Advisory Panel (CAP),
with collaborative links to NCI Program leadership and other U54 Consortia sites. The impact of our integrated
research and capacity development activities will be establishment of the H2A Consortium as partnered
Centers of Excellence on HIV and HCC in East and West Africa.
肝细胞癌(HCC)是非洲非常普遍且致命的癌症,随着HIV患者的活力
更长的时间,HCC负担可能会增加。在先前的研究中,我们的团队确定了乙型肝炎的慢性感染
和C病毒(HBV,HCV),HIV和血吸虫病Mansoni作为HCC的独立危险因素。比较的
对于美国,撒哈拉以南非洲的HCC发生在年轻时,而更高级的阶段仅生存
月份。拟议的是Makerere University的同事之间的东非和西非伙伴关系
乌干达,塞内加尔的范恩大学和约翰·霍普金斯大学专注于艾滋病毒和肝细胞
非洲癌(HCC):H2A财团。在长期合作研究的基础上进行指导
在两国的临床活动中,我们的总体目标是减轻hcc的沉重负担
撒哈拉非洲。我们主张使用适当的医疗治疗调查癌症截获策略
中断或扭转这些引起HCC引起的感染的影响。行政和协调
Core(ACC)将为实施H2A财团的科学议程提供总体领导。使用
数十年来国际研究合作的最佳实践,H2A财团提出了有效的
组织结构和强大的领导力,并具有国际研究合作的记录。这
组织框架建立在先前的co派之间正在进行的紧密工作关系的基础上
乌干达和霍普金斯并欢迎塞内加尔队成为平等伙伴。 ACC将建立
透明结构以支持严格的学习监督,有效的沟通和有效的问题 -
解决。 H2A联盟有效地将ACC活动集成到紧密相互作用的转向中
委员会(SC)由整个共同领导者和项目 /核心PI组成。对于每个项目或核心,
领导力代表着与每个网站共同责任的PIS公平合作伙伴关系。这个领导
外部咨询小组(EAP)和社区咨询小组(CAP)进一步支持了核。
通过与NCI计划领导力和其他U54联盟网站的协作链接。我们整合的影响
研究和能力开发活动将建立H2A财团
东非和西非的艾滋病毒和HCC卓越中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory D Kirk其他文献
Association of Primary Care Engagement with Initiation and Continuation of Medication Treatment for Opioid Use Disorder Among Persons with a History of Injection Drug Use
初级保健参与与有注射吸毒史的人开始和继续阿片类药物使用障碍药物治疗的关系
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:4.2
- 作者:
D. Sosnowski;K. Feder;Becky L. Genberg;S. Mehta;Gregory D Kirk - 通讯作者:
Gregory D Kirk
Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada.
美国和加拿大艾滋病毒感染者的免疫抑制和艾滋病毒病毒血症与肛门癌风险的关联。
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:11.8
- 作者:
R. Hernández;L. Qin;Haiqun Lin;W. Leyden;Romain S. Neugebauer;K. Althoff;N. Hessol;Chad J. Achenbach;J. T. Brooks;M. Gill;S. Grover;M. Horberg;Jun Li;W. C. Mathews;Á. Mayor;P. Patel;Charles S Rabkin;A. Rachlis;Amy C. Justice;Richard D. Moore;Eric A. Engels;M. Silverberg;R. Dubrow;Constance A. Benson;Ronald J. Bosch;Gregory D Kirk;Kenneth H. Mayer;C. Grasso;Robert S. Hogg;P. Richard Harrigan;J. Montaner;B. Yip;Julia Zhu;K. Salters;Karyn Gabler;K. Buchacz;Jun Li;K. Gebo;Richard D. Moore;B. Rodriguez;M. Horberg;M. Silverberg;Jennifer E. Thorne;Charles S Rabkin;Joseph B. Margolick;Lisa P. Jacobson;Gypsyamber D'Souza;M. Klein;A. Kroch;Ann N. Burchell;Adrian Betts;Joanne D. Lindsay;R. Hunter;Á. Mayor;M. John Gill;S. Deeks;Jeffrey N. Martin;J. T. Brooks;M. Saag;M. Mugavero;James Willig;W. C. Mathews;Joseph J Eron;S. Napravnik;M. Kitahata;Heidi M Crane;D. Drozd;Timothy R. Sterling;David Haas;Peter F. Rebeiro;M. Turner;Amy C. Justice;R. Dubrow;David A. Fiellin;S. Gange;K. Anastos;K. Althoff;R. Mckaig;Aimee M. Freeman;Stephen E. Van Rompaey;Liz Morton;J. McReynolds;William Lober;Jennifer S. Lee;Bin You;B. Hogan;Jinbing Zhang;Jerry Jing;E. Humes;Sally B Coburn - 通讯作者:
Sally B Coburn
Gregory D Kirk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory D Kirk', 18)}}的其他基金
Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE)
- 批准号:
10668433 - 财政年份:2020
- 资助金额:
$ 22.14万 - 项目类别:
Research Supplements to Promote Diversity in Health-Related Research
促进健康相关研究多样性的研究补充
- 批准号:
10643214 - 财政年份:2020
- 资助金额:
$ 22.14万 - 项目类别:
Antiviral treatment as prevention for HBV- and HBV/HIV-associated hepatocellular carcinoma
抗病毒治疗预防 HBV 和 HBV/HIV 相关肝细胞癌
- 批准号:
10689163 - 财政年份:2020
- 资助金额:
$ 22.14万 - 项目类别:
Antiviral treatment as prevention for HBV- and HBV/HIV-associated hepatocellular carcinoma
抗病毒治疗预防 HBV 和 HBV/HIV 相关肝细胞癌
- 批准号:
10259886 - 财政年份:2020
- 资助金额:
$ 22.14万 - 项目类别:
Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE)
- 批准号:
10223266 - 财政年份:2020
- 资助金额:
$ 22.14万 - 项目类别:
Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV
HIV 感染与肺部疾病病因学研究 (SHIELD) 空气:空气污染对 HIV 呼吸系统健康的影响
- 批准号:
10664953 - 财政年份:2020
- 资助金额:
$ 22.14万 - 项目类别:
相似海外基金
Hormonal contraception, pre-exposure prophylaxis, and HIV-1 protection
激素避孕、暴露前预防和 HIV-1 防护
- 批准号:
8626428 - 财政年份:2013
- 资助金额:
$ 22.14万 - 项目类别:
Hormonal contraception, pre-exposure prophylaxis, and HIV-1 protection
激素避孕、暴露前预防和 HIV-1 防护
- 批准号:
8537737 - 财政年份:2013
- 资助金额:
$ 22.14万 - 项目类别: